Dr. Ganesan previously served as chief of molecular oncology and associate director for translational research at New Brunswick, N.J.-based Rutgers Cancer Institute, according to an Oct. 10 news release from NYU Langone.
With the opening of the new Center for Molecular Oncology, every cancer patient receiving care at NYU Langone will receive molecular analysis. This analysis will provide a “detailed picture” of each patient’s cancer, providing insights to individualize treatment and care.
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
